WHO issues a global guideline on the use of GLP-1 medicines in treating obesity

WHO issues conditional recommendations for using these therapies to support people living with obesity in overcoming this serious health challenge, as part of a comprehensive approach that includes healthy diets, regular physical activity and support from health professionals

Source link